Researchers are increasingly examining retatrutide, a innovative medication created by Eli Lilly, as a possible step in physique loss . Unlike many existing approaches, retatrutide is a dual -action compound targeting equally GLP-1 and GIP, chemicals that impact satiety and glucose control . Early p